Archives
-
Cell and Reporter Choice in mRNA-LNP Assays
2026-09-17
Zhen et al. show that cell-line and reporter selection can substantially change apparent mRNA-LNP transfection efficiency, dose response, and assay reproducibility. HEK 293T cells and eGFP produced the most consistent in-vitro measurements, whereas luciferase performance varied by cell type and among technical replicates.
-
ARCA EGFP mRNA (5-moUTP) Workflow Guide
2026-09-17
ARCA EGFP mRNA (5-moUTP) provides a direct, fluorescence-based readout for delivery and translation in mammalian cells without requiring plasmid transcription. Its ARCA cap, 5-moUTP chemistry, and optimized poly(A) tail support consistent reporter performance while disciplined cold-chain handling improves assay reproducibility.
-
Vacuolin-1: Lysosomal Exocytosis Inhibitor
2026-09-16
Vacuolin-1 is a cell-permeable lysosomal exocytosis inhibitor that blocks Ca2+-dependent lysosome–plasma membrane fusion. Its selective activity supports β-hexosaminidase release assays, membrane-repair studies, and mechanistic analysis of lysosome-mediated membrane trafficking.
-
FerroOrange for Live-Cell Fe²⁺ Detection
2026-09-15
FerroOrange is a live-cell Fe²⁺ fluorescent probe for connecting intracellular iron detection with microscopy, flow cytometry, and plate-based assays. This workflow guide translates the Cdk5–AMPK ferroptosis findings in ischemic injury into practical assay design, controls, and troubleshooting decisions.
-
REV1–DHX36 Coordinates G-Quadruplex Tolerance
2026-09-15
The reference study identifies a direct REV1–DHX36 interaction that coordinates G-quadruplex unwinding, replication-fork progression, and suppression of single-stranded DNA gaps. Its findings establish REV1 as more than a translesion polymerase scaffold: it also regulates helicase activity and cellular tolerance of stabilized G-quadruplex DNA.
-
40 Hz GENUS Limits Epileptogenesis via the dLGN Shell
2026-09-14
Wang and colleagues show that chronic 40 Hz light flicker reduces epileptogenesis-related pathology and seizure susceptibility in a pilocarpine status epilepticus mouse model. The study further identifies a retina–dorsal lateral geniculate nucleus shell–visual cortex pathway that links sensory gamma entrainment to parvalbumin-interneuron activity.
-
Golgi-Tracker Green in Translational Oncology
2026-09-14
A mechanistic and strategic guide to using Golgi-Tracker Green for live-cell Golgi imaging, lipid trafficking studies, and translational investigation of Golgi stress in hormone receptor-positive breast cancer.
-
Troxerutin Targets TRPM7 in Diabetic Cognitive Dysfunction
2026-09-13
This study identifies a TRPM7–calcineurin–Drp1Ser637 axis that links calcium dysregulation to mitochondrial fission, neuronal apoptosis, and diabetic cognitive dysfunction. Using db/db mice and high-glucose HT22 neurons, the authors show that troxerutin improves cognitive and mitochondrial outcomes by suppressing this pathway, while also defining important limits for translation beyond the experimental models.
-
DAPI in Microbiome-Driven Cancer Research
2026-09-12
The Prevotella copri–IPyA–UHRF1–AMPK axis illustrates why translational researchers need both mechanistic assays and disciplined phenotypic quality control. This article explains how DAPI and 4',6-Diamidino-2-Phenylindole can support nuclear visualization, apoptosis-oriented analysis, viability assessment, and flow cytometry without being mistaken for a pathway-specific biomarker.
-
o-Agatoxin IVA and Excitotoxicity in Cortical Neurons
2026-09-11
The 1996 study by Lustig, Ahern, and Greenberg tested whether o-Agatoxin IVA could protect cultured cortical neurons from excitotoxic injury triggered by veratridine, ouabain, or NMDA. Its central finding was that blocking P/Q- and Q-type calcium channels did not reduce LDH-defined neuronal toxicity, emphasizing that inhibition of glutamate release is not necessarily sufficient for neuroprotection.
-
Reserpine (N1867): Practical Lab Workflow
2026-09-11
Reserpine (SKU N1867) provides a defined research reagent for controlled neurotransmitter depletion research, antihypertensive mechanism studies, and neuropharmacology research. This guide covers identity checks, DMSO preparation, storage, QC, and troubleshooting; it does not support diagnostic, therapeutic, clinical, or veterinary use.
-
Saikosaponins Target Smoothened in Medulloblastoma
2026-09-10
The 2022 Journal of Natural Medicines study shows that saikosaponins B1 and D suppress Hedgehog signaling at the Smoothened level and inhibit medulloblastoma allograft growth. Its combination of pathway reporter assays, downstream bypass experiments, and in vivo testing provides a useful framework for distinguishing Smoothened-dependent effects from nonspecific pathway suppression.
-
METTL9 and Cross-Kingdom Antifungal Defense
2026-09-10
The reference study identifies secreted intestinal METTL9 as a catalytic mucosal defense that methylates the Candida albicans zincophore PRA1, disrupting fungal zinc acquisition and limiting colonization. Its findings introduce nutritional sabotage as a distinct antifungal mechanism and provide a framework for comparing host-derived defenses with conventional drug-resistance research.
-
ARCA EGFP mRNA (5-moUTP) Assay Guide
2026-09-09
A scenario-based guide to using ARCA EGFP mRNA (5-moUTP), SKU R1007, as a fluorescence-based transfection control in mammalian-cell viability, proliferation, and cytotoxicity workflows. It explains experimental design, handling, interpretation, and vendor-selection trade-offs using product specifications and relevant mRNA-delivery evidence.
-
Maridomycin: In Vitro and In Vivo Activity
2026-09-09
Kondo and colleagues characterized maridomycin through antimicrobial-spectrum testing, resistance selection, serum-binding analysis, bactericidal assays, and mouse infection experiments. The study’s main contribution was an integrated view of activity, resistance, and therapeutic performance, while also showing why macrolide susceptibility cannot be inferred from a single assay.